| Citation: | Zhang Jingwen, Lu Ying, Li Xudong. Long-term remission of leukemia after failure of cord blood stem cell transplantation for high-risk childhood acute lymphoblastic leukemia: a report of one case and literature review[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 415-419. doi: 10.3969/j.issn.1674-7445.2015.06.014
|
| [1] |
Politikos I, Boussiotis VA. The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation[J]. Blood, 2014, 124(22):3201-3211. doi: 10.1182/blood-2014-07-589176
|
| [2] |
Zheng C, Tang B, Tong J, et al. Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia[J]. Ann Hematol, 2013, 92(12):1665-1673. doi: 10.1007/s00277-013-1820-3
|
| [3] |
Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia[J]. J Clin Oncol, 1996, 14(1):18-24. http://cn.bing.com/academic/profile?id=2119685895&encoded=0&v=paper_preview&mkt=zh-cn
|
| [4] |
Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95[J]. Blood, 2008, 111(9):4477-4489. doi: 10.1182/blood-2007-09-112920
|
| [5] |
Parma M, Vigano C, Fumagalli M, et al. Good outcome for very high risk adult b-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission[J]. Mediterr J Hematol Infect Dis, 2015, 7(1):e2015041. doi: 10.4084/mjhid.2015.041
|
| [6] |
Pulsipher MA, Peters C, Pui CH. High-risk pediatric acute lymphoblastic leukemia:to transplant or not to transplant?[J]. Biol Blood Marrow Transplant, 2011, 17(1 Suppl):S137-S148. http://cn.bing.com/academic/profile?id=2079459221&encoded=0&v=paper_preview&mkt=zh-cn
|
| [7] |
Arico M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia[J]. N Engl J Med, 2000, 342(14):998-1006. doi: 10.1056/NEJM200004063421402
|
| [8] |
阮永胜, 吴学东, 冯晓勤, 等. ALL-BFM95方案治疗儿童急性淋巴细胞白血病高危患儿的预后分析[J].中国当代儿科杂志, 2015, 17(4):327-331. http://www.cnki.com.cn/article/cjfdtotal-ddkz201504007.htm
Ruan YS, Wu XD, Feng XQ, et al. Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALLBFM 95 protocol[J]. Chin J Contemp Pediatr, 2015, 17(4):327-331. http://www.cnki.com.cn/article/cjfdtotal-ddkz201504007.htm
|
| [9] |
罗学群, 柯志勇, 黄礼彬, 等.儿童高危和超高危急性淋巴细胞白血病的预后因素分析[J].中山大学学报:医学科学版, 2008, 29(6):767-771, 776. http://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK200806031.htm
Xue Q, Ke ZY, Huang LB, et al. Analysis of prognostic factors of high-risk and very high-risk childhood acute lymphoblastic leukemia[J]. J Sun Yat-sen Univ:Med Sci, 2008, 29(6):767-771, 776. http://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK200806031.htm
|
| [10] |
Zhang H, Chen J, Que W. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients[J]. Biol Blood Marrow Transplant, 2012, 18(8):1164-1173. doi: 10.1016/j.bbmt.2012.01.015
|
| [11] |
Sun ZM. Advance in umbilical cord blood hematopoietic stem cell transplantation[J]. Chin J Pract Int Med, 2014, 34(2):127-131. http://en.cnki.com.cn/Article_en/CJFDTotal-SYNK201402009.htm
|
| [12] |
Eapen M, Klein JP, Sanz GF, et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome:a retrospective analysis[J]. Lancet Oncol, 2011, 12(13):1214-1221. doi: 10.1016/S1470-2045(11)70260-1
|
| [13] |
Munoz J, Shah N, Rezvani K, et al. Concise review:umbilical cord blood transplantation:past, present, and future[J]. Stem Cells Transl Med, 2014, 3(12):1435-1443. doi: 10.5966/sctm.2014-0151
|
| [14] |
Yao Y, Song Q, Chu Y, et al. Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression[J]. Exp Ther Med, 2014, 8(6):1946-1950. http://cn.bing.com/academic/profile?id=2092534475&encoded=0&v=paper_preview&mkt=zh-cn
|
| [15] |
肖佩芳, 胡绍燕, 何海龙, 等.异基因造血干细胞移植治疗儿童重型再生障碍性贫血疗效分析[J].中国实验血液学杂志, 2015, 23(4):1103-1107. http://www.cnki.com.cn/article/cjfdtotal-xysy201504044.htm
Xiao PF, Hu SY, He HL, et al. Efficacy analysis of allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia[J]. Chin J Exp Hematol, 2015, 23(4):1103-1107. http://www.cnki.com.cn/article/cjfdtotal-xysy201504044.htm
|
| [16] |
Liu HL, Sun ZM, Geng LQ, et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning:high graft rejection, but good survival[J]. Bone Marrow Transplant, 2012, 47(9):1186-1190. doi: 10.1038/bmt.2011.251
|
| [17] |
Zhou F, Ge L, Yu Z, et al. Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia[J]. J Hematol Oncol, 2011, 4:27. doi: 10.1186/1756-8722-4-27
|
| [18] |
Carrancio S, Blanco B, Romo C, et al. Bone marrow mesenchymal stem cells for improving hematopoietic function:an in vitro and in vivo model. part 2:effect on bone marrow microenvironment[J]. PLoS One, 2011, 6(10):e26241. doi: 10.1371/journal.pone.0026241
|
| [19] |
Castro-Manrreza ME, Montesinos JJ. Immunoregulation by mesenchymal stem cells:biological aspects and clinical applications[J]. J Immunol Res, 2015:394917. http://cn.bing.com/academic/profile?id=1982254468&encoded=0&v=paper_preview&mkt=zh-cn
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: